There is nearly complete overlap of MSI‐H or aberrant expression of MLH1, MSH2, MSH6, or PMS2 with EMAST positivity and our findings do no indicate that EMAST differentiates MSI‐H tumours into two subgroups. This evidence concerns the gene MSH6 and neoplasm.